Recent Advances in Neuraminidase Inhibitor Development as Anti-influenza Drugs
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Advances in Neuraminidase Inhibitor Development as Anti-influenza Drugs
Authors
Keywords
-
Journal
ChemMedChem
Volume 7, Issue 9, Pages 1527-1536
Publisher
Wiley
Online
2012-07-19
DOI
10.1002/cmdc.201200155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza
- (2011) Hideyuki Ikematsu et al. Expert Review of Anti-Infective Therapy
- Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario, Canada
- (2011) Jean Longtin et al. JOURNAL OF CLINICAL VIROLOGY
- A Practical Synthesis of Zanamivir Phosphonate Congeners with Potent Anti-influenza Activity
- (2011) Jiun-Jie Shie et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antivirals and resistance: influenza virus
- (2011) Michael G Ison Current Opinion in Virology
- Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition
- (2011) Christopher J. Vavricka et al. PLoS Pathogens
- Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity after a Single Administration
- (2010) S. Kubo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Advances in the Structure-Based Design of the Influenza A Neuraminidase Inhibitors
- (2010) Petar Mitrasinovic CURRENT DRUG TARGETS
- Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles
- (2010) Sankar Mohan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses
- (2010) Aaron J. Oakley et al. JOURNAL OF MEDICINAL CHEMISTRY
- Complexity in Influenza Virus Targeted Drug Design: Interaction with Human Sialidases
- (2010) Leonard M. G. Chavas et al. JOURNAL OF MEDICINAL CHEMISTRY
- The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site
- (2010) Qing Li et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Pharmacokinetics and disposition of CS-8958, a long-acting prodrug of the novel neuraminidase inhibitor laninamivir in rats
- (2010) K. Koyama et al. XENOBIOTICA
- Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase
- (2010) Santosh Rudrawar et al. Nature Communications
- Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses
- (2010) Maki Kiso et al. PLoS Pathogens
- New Antivirals and Drug Resistance
- (2009) Peter M. Colman Annual Review of Biochemistry
- CS-8958, a Prodrug of the Novel Neuraminidase Inhibitor R-125489, Demonstrates a Favorable Long-Retention Profile in the Mouse Respiratory Tract
- (2009) K. Koyama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)?
- (2009) Kunqian Yu et al. CELL RESEARCH
- Neuraminidase Inhibitor Resistance after Oseltamivir Treatment of Acute Influenza A and B in Children
- (2009) Iain Stephenson et al. CLINICAL INFECTIOUS DISEASES
- A Novel Small-Molecule Inhibitor of the Avian Influenza H5N1 Virus Determined through Computational Screening against the Neuraminidase
- (2009) Jianghong An et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synergistic Effect of Zanamivir−Porphyrin Conjugates on Inhibition of Neuraminidase and Inactivation of Influenza Virus
- (2009) Wen-Hsien Wen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Characterizing Loop Dynamics and Ligand Recognition in Human- and Avian-Type Influenza Neuraminidases via Generalized Born Molecular Dynamics and End-Point Free Energy Calculations
- (2009) Rommie E. Amaro et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Global Transmission of Oseltamivir-Resistant Influenza
- (2009) Anne Moscona NEW ENGLAND JOURNAL OF MEDICINE
- Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007–08
- (2009) Siri H Hauge et al. Virology Journal
- CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity
- (2008) M. Yamashita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors
- (2008) Jie Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis of potent pyrrolidine influenza neuraminidase inhibitors
- (2008) A. Chris Krueger et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel Druggable Hot Spots in Avian Influenza Neuraminidase H5N1 Revealed by Computational Solvent Mapping of a Reduced and Representative Receptor Ensemble
- (2008) Melissa R. Landon et al. Chemical Biology & Drug Design
- Ensemble-Based Virtual Screening Reveals Potential Novel Antiviral Compounds for Avian Influenza Neuraminidase
- (2008) Lily S. Cheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
- (2008) Patrick J. Collins et al. NATURE
- Influenza viruses and the evolution of avian influenza virus H5N1
- (2007) Nedaa Skeik et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started